MedPath

Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori SRL

🇷🇴Romania
Ownership
Private
Employees
-
Market Cap
-
Website

Italian Observational Study of Patients With Acute Myeloid Leukemia Treated With Small Molecule Inhibiting BCL-2

Conditions
Acute Myeloid Leukemia
First Posted Date
2019-08-28
Last Posted Date
2020-04-21
Lead Sponsor
Istituto Scientifico Romagnolo per lo Studio e la cura dei Tumori
Target Recruit Count
70
Registration Number
NCT04070807
Locations
🇮🇹

ASST Cremona, Cremona, CR, Italy

🇮🇹

P.O. Vito Fazzi, Lecce, LE, Italy

🇮🇹

ASST Grande Ospedale Metropolitano Niguarda, Milano, MI, Italy

and more 17 locations

Emilia-Romagna Surgical Colorectal Cancer Audit- ESCA

Conditions
Colorectal Cancer
Financial Benefit
Auditing Activity
Surgery
Interventions
Procedure: all colorectal cancer surgical procedures
First Posted Date
2019-06-11
Last Posted Date
2019-06-11
Lead Sponsor
Istituto Scientifico Romagnolo per lo Studio e la cura dei Tumori
Target Recruit Count
1400
Registration Number
NCT03982641
Locations
🇮🇹

Auo Chirurgia Generale Ospedale Degli Infermi, Rimini, Italy

🇮🇹

Istituto Scientifico Romagnolo per lo studio e la cura dei tumori, Meldola, FC, Italy

🇮🇹

AUO CHIRURGIA GENERALE OSPEDALE G. B. Morgagni- Pierantoni, Forlì, Forli-Cesena, Italy

and more 5 locations

ItaliaN Observational Study of Patients With Acute Lymphoblastic Leukemia Treated With Anti-CD22 Immunoconjugate

Conditions
Acute Lymphoblastic Leukemia
First Posted Date
2019-04-01
Last Posted Date
2021-02-26
Lead Sponsor
Istituto Scientifico Romagnolo per lo Studio e la cura dei Tumori
Target Recruit Count
120
Registration Number
NCT03898128
Locations
🇮🇹

AUSL Romagna, Ravenna, RA, Italy

🇮🇹

Irst Irccs, Meldola (FC), FC, Italy

🇮🇹

Azienda ULSS2 Marca Trevigiana, Treviso, TV, Italy

and more 2 locations

Exploring Disease Immunogenicity and the Immunological Effects of Hypomethylating Agents in Acute Myeloid Leukemia

Conditions
Acute Myeloid Leukemia
Interventions
Genetic: Immunogenic profile
First Posted Date
2018-12-31
Last Posted Date
2021-02-26
Lead Sponsor
Istituto Scientifico Romagnolo per lo Studio e la cura dei Tumori
Target Recruit Count
75
Registration Number
NCT03789981
Locations
🇮🇹

AO Spedali Civili di Brescia, Brescia, BS, Italy

🇮🇹

Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST), Meldola, FC, Italy

🇮🇹

IRCCS Casa sollievo sofferenza, San Giovanni Rotondo, Foggia, Italy

and more 11 locations

Twice High Dose External Beam Radiotherapy by Image-guided Tomotherapy for Organ-confined Prostate Cancer Treatment Emulating High Dose Radiation (HDR) Brachytherapy

Not Applicable
Terminated
Conditions
Radiotherapy; Complications
Tomotherapy
Prostate Adenocarcinoma
Interventions
Radiation: tomotherapy
First Posted Date
2018-06-12
Last Posted Date
2023-05-30
Lead Sponsor
Istituto Scientifico Romagnolo per lo Studio e la cura dei Tumori
Target Recruit Count
2
Registration Number
NCT03553212
Locations
🇮🇹

Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST), Meldola, FC, Italy

Italian Non-Interventional Study of FLT3 Mutated AML Patients

Conditions
AML
FLT3-TKD Mutation
FLT3-ITD Mutation
Interventions
Genetic: Clinical and Molecular data collection
First Posted Date
2018-06-06
Last Posted Date
2020-04-21
Lead Sponsor
Istituto Scientifico Romagnolo per lo Studio e la cura dei Tumori
Target Recruit Count
800
Registration Number
NCT03547258
Locations
🇮🇹

AOU Ospedali riuniti di Ancona, Ancona, AN, Italy

🇮🇹

AOU Policlinico Bari - Ematologia, Bari, BA, Italy

🇮🇹

Università di Bologna - DIMES, Bologna, BO, Italy

and more 30 locations

Pembrolizumab Plus Autologous Dendritic Cell Vaccine in Patients With PD-L1 Negative Advanced Mesothelioma Who Have Failed Prior Therapies

Phase 1
Active, not recruiting
Conditions
Mesothelioma, Malignant
PD-L1 Negative
Advanced Cancer
Progressive Disease
Interventions
Biological: Autologous dendritic cells
First Posted Date
2018-06-06
Last Posted Date
2024-10-01
Lead Sponsor
Istituto Scientifico Romagnolo per lo Studio e la cura dei Tumori
Target Recruit Count
18
Registration Number
NCT03546426
Locations
🇮🇹

Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST), Meldola, FC, Italy

Mp-3TMRI and 68Ga-PSMA PET/CT Guided Prostate Biopsy and Tumor Node Metastasis (TNM) Staging.

Not Applicable
Terminated
Conditions
Diagnosis
68Ga-PSMA PET/CT Guided Prostate Biopsy
Mp-3TMRI Guided Prostate Biopsy
TNM Staging
Prostate Cancer
Interventions
Diagnostic Test: pelvic MRI
Diagnostic Test: 68Ga-PSMA PET/CT
First Posted Date
2018-03-14
Last Posted Date
2025-01-30
Lead Sponsor
Istituto Scientifico Romagnolo per lo Studio e la cura dei Tumori
Target Recruit Count
261
Registration Number
NCT03465579
Locations
🇮🇹

AUSL della Romagna, Forlì, FC, Italy

🇮🇹

Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST), Meldola, FC, Italy

Optimizing the Interval Between Cycles of PRRT With 177lu-dotatate in sstr2 Positive Tumors

Phase 2
Conditions
Neuroendocrine Tumors
Interventions
Drug: PRRT every 5 weeks
Drug: PRRT every 8-10 weeks
First Posted Date
2018-03-06
Last Posted Date
2020-04-21
Lead Sponsor
Istituto Scientifico Romagnolo per lo Studio e la cura dei Tumori
Target Recruit Count
618
Registration Number
NCT03454763
Locations
🇮🇹

Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST), Meldola, FC, Italy

Radiometabolic Therapy (RMT) With 177Lu PSMA 617 in Advanced Castration Resistant Prostate Cancer (CRPC)

Phase 2
Completed
Conditions
Metastatic Castration Resistant Prostate Cancer
68Ga-PSMA PET/CT Positive
Interventions
First Posted Date
2018-03-06
Last Posted Date
2025-01-08
Lead Sponsor
Istituto Scientifico Romagnolo per lo Studio e la cura dei Tumori
Target Recruit Count
143
Registration Number
NCT03454750
Locations
🇮🇹

Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST), Meldola, FC, Italy

© Copyright 2025. All Rights Reserved by MedPath